Skip to content

Jacqueline Bore

Senior Knowledge Lawyer / Life Sciences

London

Jacqueline Bore

Senior Knowledge Lawyer / Life Sciences

London

Jacqueline is a senior lawyer with many years’ experience in advising companies in the life sciences sector on the challenges they face in developing and bringing new medicines and medical devices to the market. She has advised clients on the regulatory pathway for medicines and medical devices in Europe, in particular advising on:

Clinical trials, including transparency issues

Paediatric investigation plans,

Marketing authorisations,

Orphan medicinal products,

Manufacturing and wholesale distribution authorisations,

Supply chain issues including novel direct to patient solutions,

Parallel trade

Advertising and promotion

Relations with healthcare professionals, including bribery and corruption

Pricing and market access, including NICE submissions and appeals

Product liability, including managing substantial multiparty actions.

Jacqueline has advised on a number of judicial reviews challenging regulatory decisions of both MHRA and the EMA and has defended product liability claims in the House of Lords, Supreme Court and the Court of Justice of the European Union.

Jacqueline practised medicine for 8 years before qualifying as a solicitor.

Related articles

Close-up medical syringe with a vaccine

Blog Post: 02 March 2023

The Windsor Framework: MHRA to have power to licence all types of medicines to be supplied in the United Kingdom in single pack

The European Commission and the United Kingdom government announced on Monday that they have come to agreement on measures to alleviate the remaining practical difficulties in the supply of medicines…

Read more The Windsor Framework: MHRA to have power to licence all types of medicines to be supplied in the United Kingdom in single pack

Blog Post: 28 October 2022

EC Decision reliance procedure for GB Marketing Authorisations extended by MHRA for one year to 31 December 2023

Read more EC Decision reliance procedure for GB Marketing Authorisations extended by MHRA for one year to 31 December 2023

Blog Post: 18 October 2022

Paediatric medicines in the EU, the UK and the U.S.: regulatory framework in a nutshell

Read more Paediatric medicines in the EU, the UK and the U.S.: regulatory framework in a nutshell

Publications: 12 January 2021

Brexit certainty at last? An overview of the new EU-UK trading relationship

Read more Brexit certainty at last? An overview of the new EU-UK trading relationship

Expertise

Practices

Intellectual Property

Sectors

Life Sciences

Office

London

One Bishops Square
London
E1 6AD

View office →

Qualifications

Professional

Admitted as a solicitor (England and Wales), 1995

Academic

MA Jurisprudence, Oxford University, 1980

MB,BS Medicine, Guy’s Hospital, 1983

Postgraduate Diploma in European Union Law, King’s College, London 2011